On September 28, 2016, the 14th participant was enrolled in our ongoing Phase 1 study of the psychological effects of MDMA when taken in a therapeutic setting by healthy volunteers in Charleston, South Carolina. The Charleston site is led by Michael Mithoefer, M.D. On September 26 and September 28, 2016, the first and second participants were enrolled and treated at the recently initiated Boulder, Colorado study site. Marcela Ot’alora, M.A., L.P.C., is serving as Principal Investigator of the Boulder site.
